Respiratory Trials·org

Lung cancer · Sampling the pulmonary nodule

VERITAS randomised trial

Navigational Bronchoscopy or Transthoracic Needle Biopsy for Lung Nodules

VERITAS trial design and results
Design Randomised equivalence trial
Treatment Navigational bronchoscopy
Control Transthoracic needle biopsy
Population 234 patients with peripheral pulmonary nodules measuring 10 to 30 mm
Follow-up 12 months
Primary endpoint Diagnostic accuracy, confirmed through month 12
Result A specific, accurate diagnosis was obtained in 94 of 119 (79.0%) with navigational bronchoscopy, non-inferior to transthoracic needle biopsy (p=0.003 for non-inferiority, p=0.17 for superiority). Pneumothorax occurred in 4 of 121 (3.3%) versus 32 of 113 (28.3%), requiring a chest drain or admission in 0.8% versus 11.5%.
Secondary endpoints Pneumothorax, chest tube placement, hospital admission

The diagnostic accuracy of navigational bronchoscopy was noninferior to that of transthoracic needle biopsy among patients with peripheral pulmonary nodules measuring 10 to 30 mm.

The trial authors, in the published abstract

How it has aged

The accuracy result is non-inferiority; the reason to change practice is the complication rate — 3.3% pneumothorax against 28.3%. As screening (NELSON, NLST) generates more nodules needing tissue, the safer route to a diagnosis matters more.

Publications

Navigational Bronchoscopy or Transthoracic Needle Biopsy for Lung Nodules

Lentz RJ, Frederick-Dyer K, Planz VB, et al. Navigational Bronchoscopy or Transthoracic Needle Biopsy for Lung Nodules. N Engl J Med 2025 Jun 5;392(21):2100-2112.

  • Diagnostic accuracy non-inferior to transthoracic needle biopsy
  • Pneumothorax 3.3% versus 28.3%
  • Chest drain or admission needed in 0.8% versus 11.5%